| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |